Lucidi Bruno — SEC insider filings
SEC reporting owner CIK 1829622. 9 insider filings on record with FilingPulse; latest filed 2026-11-19.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2020-10-30 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 29,360 shares, $116,410 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 22,619 shares @ $3.94 ($89,221) in Atea Pharmaceuticals, Inc., filed 2026-11-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | Director | 9 | — | 2 legs · 29,360 sh · $116,410 | 21 |
Insider filings — Lucidi Bruno
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-19 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 21,628 @ $1.24 · Sale (S): 6,741 @ $4.03 · Option exercise (M): 53,372 @ $1.24 · Sale (S): 22,619 @ $3.94 · Option exercise (M): 21,628 (derivative) @ $0 · Option exercise (M): 53,372 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 29,600 @ $0 · Option exercise (M): 29,600 (derivative) @ $0 · Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 37,700 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 29,600 @ $0 · Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0 · Option exercise (M): 29,600 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 33,150 @ $0 · Option exercise (M): 33,150 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/award (A): 33,150 (derivative) @ $0 · Grant/award (A): 46,750 (derivative) @ $0 | EDGAR |
| 2022-06-21 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/award (A): 61,264 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/award (A): 34,025 (derivative) @ $0 | EDGAR |
| 2020-10-30 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1829622 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs